Idrabiotaparinux - Licensing opportunity
Idiopathic pulmonary fibrosis trials: recommendations for the jury EDITORIAL
Idiopathic pulmonary fibrosis
Idiopathic Parkinson`s disease
IDE_IND_KMFINAL_plusAEslide_090310
Idera Pharmaceuticals Presents Data Supporting IMO
Idera Pharmaceuticals Expands Pipeline by Initiating Clinical
Identifying Pseudobulbar Affect in Alzheimer`s
Identifying Potential Adverse Drug Events in Tweets Using
Identifying compound efficacy targets in phenotypic drug discovery
Identifying and establishing consensus on the most important safety
Identification of the peptide conjugate with toxic acetaminophen
Identification of the date-rape drug GHB and its precursor GBL by
Identification of osteoarthritis patients with chronic tissue
Identification of novel therapeutics for complex diseases from
Identification of novel natural compound inhibitors for human
IDENTIFICATION OF NATURAL PRODUCTS AS ANTIDIABETIC AGENTS Laura Guasch Pàmies
Identification of GZD824 as an Orally Bioavailable Inhibitor That
Identification of Epidermal Growth Factor
IDENTIFICATION OF DUAL AGONISTIC NOVEL LIGANDS FOR INSULIN RECEPTOR AND... THROUGH MOLECULAR DOCKING
